EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Impact of systematic variations in hematocrit and platelet count on thrombelastometry tissue factor activated assay parameters

Julie T Skaugen iD, Mark H Yazer, Ulrik Sprogøe iD

Transfusion · 2024

DOI: 10.1111/trf.17809 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, 2024. Verfasst von Julie T Skaugen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology, Odense University Hospital, Odense, Denmark. Hauptthemen laut MEDLINE: Thrombelastography. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Thromboelastogram testing is increasingly being used to manage patients with massive bleeding. An earlier study found that the test results were influenced by the hematocrit (Hct) and platelet (PLT) concentrations. This study sought to determine if these factors confounded the results of a different manufacturer's thromboelastography testing.

Methods

Using freshly collected whole blood from volunteers and stored red blood cells (RBC) and plasma, the whole blood was manipulated to achieve different Hct values and PLT concentrations. Each reconstituted whole blood sample was tested in triplicate on the ROTEM Delta device and the ExTEM results were recorded.

Results

Many of the ExTEM results varied according to the Hct and PLT concentration. In particular, the ExTEM clot formation time (CFT) was abnormally long when the Hct was 45% and the PLT concentration was ≤75 × 10 9 /L, normalizing only when the PLT count was ≥100 × 10 9 /L. CFT samples with Hct 25% and 35% were also abnormal with low PLT concentrations but normalized at lower PLT concentrations compared to the Hct 45% samples. The ExTEM angle also demonstrated abnormal results when the Hct was 45% and the PLT concentration was ≤50 × 10 9 /L. The ExTEM A10 and maximum clot firmness (MCF) tests tended to also be abnormal when the Hct was between 25% and 45% and the platelet concentrations were below 75 × 10 9 /L.

Conclusion

While thromboelastogram testing is gaining popularity for managing bleeding patients, clinicians should be aware of these confounding factors when making transfusion decisions based on their results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombelastographyHumansHematocritPlatelet CountThromboplastinFemaleBlood CoagulationMale

Stichwörter der Autor:innen

EXTEMROTEMhematocritplatelettestingthrombelastometry

Substanzen

Thromboplastin

Autor:innen und Institutionen

  • Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
  • Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • University of Southern Denmark, Odense, Denmark.

ORCID-Profile: Julie T Skaugen, Ulrik Sprogøe

Zitieren

APA

Skaugen, J. T., Yazer, M. H., & Sprogøe, U. (2024). Impact of systematic variations in hematocrit and platelet count on thrombelastometry tissue factor activated assay parameters. Transfusion. https://doi.org/10.1111/trf.17809

Vancouver

Skaugen JT, Yazer MH, Sprogøe U. Impact of systematic variations in hematocrit and platelet count on thrombelastometry tissue factor activated assay parameters. Transfusion. 2024. doi:10.1111/trf.17809

BibTeX
@article{Skaugen2024,
  author = {Skaugen, Julie T and Yazer, Mark H and Sprogøe, Ulrik},
  title = {Impact of systematic variations in hematocrit and platelet count on thrombelastometry tissue factor activated assay parameters},
  journal = {Transfusion},
  year = {2024},
  doi = {10.1111/trf.17809}
}
Kostenlos starten →